{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T08:41:49Z","timestamp":1761986509214,"version":"build-2065373602"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,11,1]]},"DOI":"10.7759\/cureus.95882","type":"journal-article","created":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T08:37:51Z","timestamp":1761986271000},"source":"Crossref","is-referenced-by-count":0,"title":["Evaluation of Cutaneous Manifestations in Patients With Diabetes Mellitus: Association With Non-alcoholic Fatty Liver Disease and Other Gastrointestinal Complications"],"prefix":"10.7759","author":[{"given":"Dilaram","family":"Khan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junaid","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Momna","family":"Arif","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kainat","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jawad","family":"Bari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farhan","family":"Ali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tajala","family":"Fayyaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salman","family":"Haider","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanif Ullah","family":"Hanfi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naqeeb","family":"Ullah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Type 2 Diabetes","author":"Goyal R","year":"2025","unstructured":"Goyal R, Singhal M, Jialal I. Type 2 Diabetes. In: StatPearls [Internet] (ed): StatPearls Publishing, Treasure Island, FL; 2025."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(23)01301-6","article-title":"Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021","volume":"402","author":"Ong KL","year":"2023","unstructured":"Ong KL, Stafford LK, McLaughlin SA, et al.. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. 2023, 402:203-34. 10.1016\/S0140-6736(23)01301-6","journal-title":"Lancet"},{"key":"ref3","article-title":"IDF Diabetes Atlas","author":"Magliano DJ","year":"2025","unstructured":"Magliano DJ, Boyko EJ, Genitsaridi I, Piemonte L, Riley P, Salpea P. IDF Diabetes Atlas. 11th edition (ed): International Diabetes Federation, Brussels, Belgium; 2025."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3389\/fcdhc.2023.1338656","article-title":"Editorial: current understanding of complications associated with diabetes","volume":"4","author":"Srivastava SP","year":"2023","unstructured":"Srivastava SP. Editorial: current understanding of complications associated with diabetes. Front Clin Diabetes Healthc. 2023, 4:1338656. 10.3389\/fcdhc.2023.1338656","journal-title":"Front Clin Diabetes Healthc"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3390\/diabetology6030018","article-title":"Dermatological manifestations of diabetes mellitus and its complications","volume":"6","author":"Ly L","year":"2025","unstructured":"Ly L, Vo KL, Cruel AC, Shubrook JH. Dermatological manifestations of diabetes mellitus and its complications. Diabetology. 2025, 6:18. 10.3390\/diabetology6030018","journal-title":"Diabetology"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.4103\/ijd.ijd_155_21","article-title":"Metabolic syndrome and skin: interactions and implications","volume":"67","author":"Ambalal SM","year":"2022","unstructured":"Ambalal SM. Metabolic syndrome and skin: interactions and implications. Indian J Dermatol. 2022, 67:138-45. 10.4103\/ijd.ijd_155_21","journal-title":"Indian J Dermatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.5114\/dr.2020.96363","article-title":"Prevalence of skin lesions in patients with diabetes in Iran: a systematic review and meta-analysis","volume":"107","author":"Sobhiyeh MR","year":"2020","unstructured":"Sobhiyeh MR, Mohamadi M, Khatony A. Prevalence of skin lesions in patients with diabetes in Iran: a systematic review and meta-analysis. Dermatol Rev. 2020, 107:191-4. 10.5114\/dr.2020.96363","journal-title":"Dermatol Rev"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.31744\/einstein_journal\/2025RW1193","article-title":"Cutaneous manifestations of diabetes mellitus: a narrative review","volume":"23","author":"Abate MC","year":"2025","unstructured":"Abate MC, Aroucha PM, N\u00f3brega DV, et al.. Cutaneous manifestations of diabetes mellitus: a narrative review. Einstein (Sao Paulo). 2025, 23:eRW1193. 10.31744\/einstein_journal\/2025RW1193","journal-title":"Einstein (Sao Paulo)"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3390\/diseases11030106","article-title":"Cutaneous manifestations associated with diabetes mellitus-a retrospective study","volume":"11","author":"V\u00e2\u021b\u0103 D","year":"2023","unstructured":"V\u00e2\u021b\u0103 D, Stanciu DE, Temelie-Olinici D, Porumb-Andrese E, Tarc\u0103u BM, Grecu VB, Gheuc\u0103-Solov\u0103stru L. Cutaneous manifestations associated with diabetes mellitus-a retrospective study. Diseases. 2023, 11:106. 10.3390\/diseases11030106","journal-title":"Diseases"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.4103\/amsr.amsr_57_22","article-title":"Cutaneous manifestations of diabetes mellitus: correlation with HbA1C level\u2014A cross-sectional observational study from a tertiary care center in Eastern India","volume":"2","author":"Mandal N","year":"2023","unstructured":"Mandal N, Praveen P, Sen S, Banerjee S, Dey P, Mandal S. Cutaneous manifestations of diabetes mellitus: correlation with HbA1C level\u2014A cross-sectional observational study from a tertiary care center in Eastern India. Ann Med Sci Res. 2023, 2:144-50. 10.4103\/amsr.amsr_57_22","journal-title":"Ann Med Sci Res"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11175223","article-title":"Gastrointestinal and liver complications in patients with diabetes mellitus-a review of the literature","volume":"11","author":"Mare R","year":"2022","unstructured":"Mare R, Sporea I. Gastrointestinal and liver complications in patients with diabetes mellitus-a review of the literature. J Clin Med. 2022, 11:5223. 10.3390\/jcm11175223","journal-title":"J Clin Med"},{"key":"ref12","article-title":"Non-alcoholic fatty liver disease: global scenario, challenges, and preparedness","volume":"28","author":"Roy A","year":"2023","unstructured":"Roy A, Goenka MK. Non-alcoholic fatty liver disease: global scenario, challenges, and preparedness. World Gastroenterol Organ. 2023, 28:1.","journal-title":"World Gastroenterol Organ"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3390\/life14020272","article-title":"NAFLD fibrosis progression and type 2 diabetes: the hepatic-metabolic interplay","volume":"14","author":"Cernea S","year":"2024","unstructured":"Cernea S. NAFLD fibrosis progression and type 2 diabetes: the hepatic-metabolic interplay. Life (Basel). 2024, 14:272. 10.3390\/life14020272","journal-title":"Life (Basel)"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1136\/bmjdrc-2018-000514","article-title":"Lower gastrointestinal symptoms are associated with worse glycemic control and quality of life in type 1 diabetes mellitus","volume":"6","author":"Leeds JS","year":"2018","unstructured":"Leeds JS, Hadjivassiliou M, Tesfaye S, Sanders DS. Lower gastrointestinal symptoms are associated with worse glycemic control and quality of life in type 1 diabetes mellitus. BMJ Open Diabetes Res Care. 2018, 6:e000514. 10.1136\/bmjdrc-2018-000514","journal-title":"BMJ Open Diabetes Res Care"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v27.i41.7113","article-title":"Non-alcoholic fatty liver disease in patients with intestinal, pulmonary or skin diseases: inflammatory cross-talk that needs a multidisciplinary approach","volume":"27","author":"Perez-Carreras M","year":"2021","unstructured":"Perez-Carreras M, Casis-Herce B, Rivera R, Fernandez I, Martinez-Montiel P, Villena V. Non-alcoholic fatty liver disease in patients with intestinal, pulmonary or skin diseases: inflammatory cross-talk that needs a multidisciplinary approach. World J Gastroenterol. 2021, 27:7113-24. 10.3748\/wjg.v27.i41.7113","journal-title":"World J Gastroenterol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.21.4.506","article-title":"The prevalence of cutaneous manifestations in IDDM patients and their association with diabetes risk factors and microvascular complications","volume":"21","author":"Yosipovitch G","year":"1998","unstructured":"Yosipovitch G, Hodak E, Vardi P, Shraga I, Karp M, Sprecher E, David M. The prevalence of cutaneous manifestations in IDDM patients and their association with diabetes risk factors and microvascular complications. Diabetes Care. 1998, 21:506-9. 10.2337\/diacare.21.4.506","journal-title":"Diabetes Care"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.38961","article-title":"A comprehensive overview of skin complications in diabetes and their prevention","volume":"15","author":"David P","year":"2023","unstructured":"David P, Singh S, Ankar R. A comprehensive overview of skin complications in diabetes and their prevention. Cureus. 2023, 15:e38961. 10.7759\/cureus.38961","journal-title":"Cureus"},{"key":"ref18","doi-asserted-by":"crossref","DOI":"10.18203\/issn.2455-4529.IntJResDermatol20183157","article-title":"Cutaneous manifestations of diabetes mellitus: a clinical study","volume":"4","author":"Bhardwaj N","year":"2018","unstructured":"Bhardwaj N, Roy S, Jindal R, Ahmad S. Cutaneous manifestations of diabetes mellitus: a clinical study. Int J Res Dermatol. 2018, 4:352-6.","journal-title":"Int J Res Dermatol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1007\/s40200-020-00629-7","article-title":"Evaluation of skin lesions in diabetic patients: a systematic review and meta-analysis","volume":"19","author":"Salari N","year":"2020","unstructured":"Salari N, Hosseinian-Far A, Hosseinian-Far M, et al.. Evaluation of skin lesions in diabetic patients: a systematic review and meta-analysis. J Diabetes Metab Disord. 2020, 19:1909-16. 10.1007\/s40200-020-00629-7","journal-title":"J Diabetes Metab Disord"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.22092\/ARI.2021.356588.1874","article-title":"Non-infectious dermatological manifestations among patients with diabetes mellitus in Basrah, Iraq","volume":"77","author":"Sabah Abdulridha Budair A","year":"2022","unstructured":"Sabah Abdulridha Budair A, Ismail Al Hamdi K, Ali Mansour A. Non-infectious dermatological manifestations among patients with diabetes mellitus in Basrah, Iraq. Arch Razi Inst. 2022, 77:467-75. 10.22092\/ARI.2021.356588.1874","journal-title":"Arch Razi Inst"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.85510","article-title":"Fatty liver disease in the diabetic population: a cross-sectional study from Pakistan","volume":"17","author":"Liaquat Memon H","year":"2025","unstructured":"Liaquat Memon H, Farooq S, Aslam M, Hyder A, Tareen K, Ahmed I, Khan RT. Fatty liver disease in the diabetic population: a cross-sectional study from Pakistan. Cureus. 2025, 17:e85510. 10.7759\/cureus.85510","journal-title":"Cureus"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1177\/11795514251345047","article-title":"Acanthosis nigricans as a clinical risk marker for metabolic dysfunction-associated steatotic liver disease","volume":"18","author":"S\u00e1nchez-Garc\u00eda A","year":"2025","unstructured":"S\u00e1nchez-Garc\u00eda A, Penados-Ovalle ME, Rodr\u00edguez-Guti\u00e9rrez R, D\u00edaz-Gonz\u00e1lez Colmeneros F, Gonz\u00e1lez-Gonz\u00e1lez JG. Acanthosis nigricans as a clinical risk marker for metabolic dysfunction-associated steatotic liver disease. Clin Med Insights Endocrinol Diabetes. 2025, 18:11795514251345047. 10.1177\/11795514251345047","journal-title":"Clin Med Insights Endocrinol Diabetes"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1177\/20503121221124762","article-title":"Assessment of fatty liver and its correlation with glycemic control in patients with type 2 diabetes mellitus attending Dessie Comprehensive Specialized Hospital, Northeast Ethiopia","volume":"10","author":"Abebe G","year":"2022","unstructured":"Abebe G, Ayanaw D, Ayelgn Mengstie T, Dessie G, Malik T. Assessment of fatty liver and its correlation with glycemic control in patients with type 2 diabetes mellitus attending Dessie Comprehensive Specialized Hospital, Northeast Ethiopia. SAGE Open Med. 2022, 10:20503121221124762. 10.1177\/20503121221124762","journal-title":"SAGE Open Med"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000039895","article-title":"Prevalence of gastrointestinal manifestations among diabetic patients in the Aseer region: a cross-sectional study","volume":"103","author":"Alshaikh AA","year":"2024","unstructured":"Alshaikh AA, Alshehri AA, Alshehri AZ, et al.. Prevalence of gastrointestinal manifestations among diabetic patients in the Aseer region: a cross-sectional study. Medicine (Baltimore). 2024, 103:e39895. 10.1097\/MD.0000000000039895","journal-title":"Medicine (Baltimore)"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.pcd.2024.01.003","article-title":"Acanthosis nigricans independently predicts hepatic fibrosis in people with type 2 diabetes in North India","volume":"18","author":"Dutta K","year":"2024","unstructured":"Dutta K, Bhatt SP, Madan S, Ansari IA, Tyagi K, Pandey S, Misra A. Acanthosis nigricans independently predicts hepatic fibrosis in people with type 2 diabetes in North India. Prim Care Diabetes. 2024, 18:224-9. 10.1016\/j.pcd.2024.01.003","journal-title":"Prim Care Diabetes"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1186\/s12986-025-00924-1","article-title":"Metabolic syndrome and dermatological diseases: association and treatment","volume":"22","author":"Xia J","year":"2025","unstructured":"Xia J, Ding L, Liu G. Metabolic syndrome and dermatological diseases: association and treatment. Nutr Metab (Lond). 2025, 22:36. 10.1186\/s12986-025-00924-1","journal-title":"Nutr Metab (Lond)"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/413584-evaluation-of-cutaneous-manifestations-in-patients-with-diabetes-mellitus-association-with-non-alcoholic-fatty-liver-disease-and-other-gastrointestinal-complications","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T08:37:52Z","timestamp":1761986272000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/413584-evaluation-of-cutaneous-manifestations-in-patients-with-diabetes-mellitus-association-with-non-alcoholic-fatty-liver-disease-and-other-gastrointestinal-complications"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,1]]},"references-count":26,"URL":"https:\/\/doi.org\/10.7759\/cureus.95882","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11,1]]}}}